Welcome to our dedicated page for Trinity Capital news (Ticker: TRINL), a resource for investors and traders seeking the latest updates and insights on Trinity Capital stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Trinity Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Trinity Capital's position in the market.
Trinity Capital Inc. (NASDAQ: TRIN) has priced a public offering of $100.0 million in 7.875% notes due 2029. The notes will mature on September 30, 2029, and can be redeemed after September 30, 2026. Trinity has granted underwriters a 30-day option to purchase up to $15.0 million in additional notes. The offering is expected to close on July 19, 2024, with the notes to be listed on Nasdaq under the symbol 'TRINI'.
Trinity plans to use the net proceeds to pay down existing debt under its KeyBank Credit Facility and potentially redeem a portion of its outstanding 7.00% Notes due 2025. The offering is being managed by several financial institutions, including Keefe, Bruyette & Woods, Morgan Stanley, RBC Capital Markets, and UBS Investment Bank as joint book-running managers.
Trinity Capital (NASDAQ: TRIN, TRINL) announced a $40 million financing facility to support Convergent Dental, the creator of the Solea® dental laser. Of this amount, $20 million has already been drawn, with an option for Convergent to access an additional $20 million, contingent on agreement terms. The Solea® laser technology is unique as it allows for anesthesia-free dental procedures, enhancing patient comfort and operational efficiency for dental practices. This funding aims to help Convergent accelerate its growth and expand the market adoption of its innovative product. Trinity Capital, known for its specialized financial solutions to growth-stage companies, reinforces its commitment to driving advancements in the life sciences sector.
Trinity Capital Inc. (Nasdaq: TRIN, TRINL) announced that it will host its first quarter 2023 conference call on May 4, 2023, at 3:00 p.m. PT (6:00 p.m. ET). Investors can listen by dialing (800) 343-4849 or (203) 518-9856 and referencing Conference ID: TRINQ123. A taped replay will be available approximately two hours after the call and will remain accessible until May 11, 2023. A live webcast will also be available on Trinity's investor relations website. Trinity Capital is a provider of diversified financial solutions to growth-stage companies, aiming to generate current income and capital appreciation through various investment methods.
Trinity Capital Inc. (Nasdaq: TRIN, TRINL) has announced the release of its first quarter 2023 financial results, scheduled for May 4, 2023, after market close. A conference call to discuss these results will occur at 2:00 p.m. PT (5:00 p.m. ET) on the same day. Investors can participate by dialing (800) 343-4849 or (203) 518-9856 and referencing Conference ID: TRINQ123. A live webcast will also be available on the company's investor relations website. Furthermore, a replay of the call will be accessible for 90 days post-event. Trinity Capital specializes in providing diversified financial solutions to growth-stage companies, combining term loans and equity-related investments to generate income and capital appreciation.
Trinity Capital reported strong financial results for Q4 and the full year 2022, highlighting a 75.8% increase in total investment income to $41.5 million. Net investment income surged by 103.8% to $21.6 million, equating to $0.62 per share. Total gross investments funded reached $120.8 million, with aggregate commitments totaling $239.5 million. Despite a decrease in net asset value per share from $13.74 to $13.15, the company declared a dividend of $0.61, supported by a coverage ratio of 135%. Notably, net realized losses were reported at $9.6 million, mainly due to two portfolio companies. Overall, Trinity's strong originations and strategic growth initiatives position it favorably for 2023.
FAQ
What is the current stock price of Trinity Capital (TRINL)?
